USANA Health Sciences, Inc. USNA

14.50 0.24 1.68% as of 25 Sep
Market cap
$263.5M
P/E
0.0×

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Net Income 100.04 62.54 126.22 100.53 124.66 116.51 69.35 63.79 42.06 11.48
Depreciation & Amortization 13.48 16.11 16.84 23.01 22.51 22.19 21.41 20.40 22.23 39.70
Non Cash Items (Other) 12.96 37.54 16.80 11.99 12.67 15.59 12.37 14.46 9.71 14.25
Change in inventories (1.03) 6.05 (23.10) 12.99 (16.78) (14.70) 15.80 2.35 (2.12) (34.68)
Accounts Payable Change (1.34) 3.04 (1.72) 1.84 6.08 (4.57) (2.66) (0.43) (1.27) 5.20
Change in other assets and liabilities 12.79 (1.51) 17.07 (23.61) 11.26 (13.79) (12.37) (29.92) (9.62) (13.60)
Operating Cash Flow 136.89 123.77 152.12 126.73 160.40 121.23 103.90 70.64 60.99 22.35
Capital expenditures (32.69) (13.20) (11.05) (16.55) (15.09) (12.75) (10.39) (14.48) (10.01) (9.92)
Net Aquisitions (0.01) — — — — — (6.53) — (203.34) —
Long-Term Investments Change (Net) — — (63.54) 63.54 (20.00) — — — — —
Other investing activities 0.81 0.30 5.59 0.51 1.13 (1.44) 4.56 2.50 0.26 (0.21)
Investing cash flow (31.88) (12.90) (69.00) 47.49 (33.96) (14.19) (12.37) (11.97) (213.09) (10.12)
Repayment/Issuance of Debt (Net) (0.25) — — (0.06) (0.05) — — 0.79 22.22 (9.00)
Equity Repurchase (Common, Net) (64.61) (50.00) (105.37) (150.00) (57.03) (177.84) (25.38) (11.60) (9.44) (27.51)
Dividends Paid (Total) — — — — — — — — — (1.75)
Other financial activities (0.25) (0.32) 0.10 (1.99) (2.37) (3.57) (4.71) (3.43) (3.22) (2.35)
Financing cash flow (64.86) (50.32) (105.28) (152.05) (59.44) (181.41) (30.09) (14.24) 9.55 (40.60)
Exchange Rate Adjustment (7.93) 11.03 (11.14) (1.72) 11.25 2.09 (13.78) (2.50) (6.19) 5.11
Change in Cash 32.22 71.58 (33.30) 20.45 78.25 (72.28) 47.67 41.93 (148.74) (23.27)
Beginning Cash 146.73 178.95 250.54 217.23 237.69 315.94 243.65 291.32 333.25 184.51
Ending Cash 178.95 250.54 217.23 237.69 315.94 243.65 291.32 333.25 184.51 161.24
Stock Based Compensation 16.54 15.48 14.96 15.54 14.39 14.30 13.33 14.60 14.56 13.83
Dividends Paid (Common) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 (1.75)
Net Cash/Marketcap 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Assets Liabilities Change (Total) 10.41 7.59 (7.75) (8.79) 0.56 (33.06) 0.77 (28.00) (13.00) (43.08)
Investments Change (Net) — — (63.54) 63.54 (20.00) — — — — —
Issuance/Purchase of Shares (64.61) (50.00) (105.37) (150.00) (57.03) (177.84) (25.38) (11.60) (9.44) (27.51)
Other line items
Revenue per Employee 0.56 0.58 0.62 0.56 0.58 0.60 0.53 0.51 0.50 0.59

Fold the line items

In millions of $ except per-share values · columns are period end dates